Skip to main content
Journal cover image

AT-46 VORINOSTAT AND BEVACIZUMAB FOR RECURRENT HIGH-GRADE GLIOMA: INTERIM ANALYSIS OF A PHASE II CLINICAL TRIAL

Publication ,  Conference
Peters, K; Reardon, D; Randazzo, D; Dutton, S; Edwards, A; Lipp, E; Herndon, J; McSherry, F; Desjardins, A; Ranjan, T; Vlahovic, G; Friedman, H
Published in: Neuro-Oncology
November 1, 2014

AT-46

Duke Scholars

Published In

Neuro-Oncology

DOI

EISSN

1523-5866

ISSN

1522-8517

Publication Date

November 1, 2014

Volume

16

Issue

suppl 5

Start / End Page

v18 / v18

Location

Miami, FL

Publisher

Oxford University Press (OUP)

Conference Name

19th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology (SNO),

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1109 Neurosciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Peters, K., Reardon, D., Randazzo, D., Dutton, S., Edwards, A., Lipp, E., … Friedman, H. (2014). AT-46 VORINOSTAT AND BEVACIZUMAB FOR RECURRENT HIGH-GRADE GLIOMA: INTERIM ANALYSIS OF A PHASE II CLINICAL TRIAL. In Neuro-Oncology (Vol. 16, pp. v18–v18). Miami, FL: Oxford University Press (OUP). https://doi.org/10.1093/neuonc/nou237.45
Peters, K., D. Reardon, D. Randazzo, S. Dutton, A. Edwards, E. Lipp, J. Herndon, et al. “AT-46 VORINOSTAT AND BEVACIZUMAB FOR RECURRENT HIGH-GRADE GLIOMA: INTERIM ANALYSIS OF A PHASE II CLINICAL TRIAL.” In Neuro-Oncology, 16:v18–v18. Oxford University Press (OUP), 2014. https://doi.org/10.1093/neuonc/nou237.45.
Peters K, Reardon D, Randazzo D, Dutton S, Edwards A, Lipp E, et al. AT-46 VORINOSTAT AND BEVACIZUMAB FOR RECURRENT HIGH-GRADE GLIOMA: INTERIM ANALYSIS OF A PHASE II CLINICAL TRIAL. In: Neuro-Oncology. Oxford University Press (OUP); 2014. p. v18–v18.
Peters, K., et al. “AT-46 VORINOSTAT AND BEVACIZUMAB FOR RECURRENT HIGH-GRADE GLIOMA: INTERIM ANALYSIS OF A PHASE II CLINICAL TRIAL.” Neuro-Oncology, vol. 16, no. suppl 5, Oxford University Press (OUP), 2014, pp. v18–v18. Manual, doi:10.1093/neuonc/nou237.45.
Peters K, Reardon D, Randazzo D, Dutton S, Edwards A, Lipp E, Herndon J, McSherry F, Desjardins A, Ranjan T, Vlahovic G, Friedman H. AT-46 VORINOSTAT AND BEVACIZUMAB FOR RECURRENT HIGH-GRADE GLIOMA: INTERIM ANALYSIS OF A PHASE II CLINICAL TRIAL. Neuro-Oncology. Oxford University Press (OUP); 2014. p. v18–v18.
Journal cover image

Published In

Neuro-Oncology

DOI

EISSN

1523-5866

ISSN

1522-8517

Publication Date

November 1, 2014

Volume

16

Issue

suppl 5

Start / End Page

v18 / v18

Location

Miami, FL

Publisher

Oxford University Press (OUP)

Conference Name

19th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology (SNO),

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1109 Neurosciences